Back to Search
WADIH ARAP, M.D., PHD
M.D., PHD
Hematology & Oncology Physician
NPI: 1487743092IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD2013-0750(NM)
Education
OTHER
Class of 1983
Research & Publications (20)
Combinatorial targeting and nanotechnology applications.
PMID 19669890·Biomed Microdevices·2010
8-other
The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples.
PMID 19244100·Cancer Res·2009
7-preclinical
Intravascular delivery of particulate systems: does geometry really matter?
PMID 18712584·Pharm Res·2009
6-review
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
PMID 19636008·J Clin Oncol·2009
3-trial
Role of leukemia cell invadosome in extramedullary infiltration.
PMID 19636064·Blood·2009
7-preclinical
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.
PMID 19224553·Cancer·2009
7-preclinical
Discovery of a functional protein complex of netrin-4, laminin gamma1 chain, and integrin alpha6beta1 in mouse neural stem cells.
PMID 19193855·Proc Natl Acad Sci U S A·2009
7-preclinical
A heterotypic bystander effect for tumor cell killing after adeno-associated virus/phage-mediated, vascular-targeted suicide gene transfer.
PMID 19671758·Mol Cancer Ther·2009
7-preclinical
Targeting cancer-specific synthetic lethality in double-strand DNA break repair.
PMID 19440052·Cell Cycle·2009
6-review
An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment.
PMID 19168626·Proc Natl Acad Sci U S A·2009
7-preclinical
Ceramide-mediated apoptosis following ionizing radiation in human prostate cancer cells: PKCalpha joins the fray.
PMID 19127120·Cancer Biol Ther·2009
8-other
Tumor vasculature-targeted delivery of tumor necrosis factor-alpha.
PMID 19090007·Cancer·2009
7-preclinical
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature.
PMID 19330034·PLoS One·2009
3-trial
Targeting the extracellular signature of metastatic colorectal cancers.
PMID 19236157·Expert Opin Ther Targets·2009
6-review
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models.
PMID 19491274·Cancer Res·2009
7-preclinical
Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?
PMID 19010879·Cancer Res·2008
6-review
A ligand peptide motif selected from a cancer patient is a receptor-interacting site within human interleukin-11.
PMID 18941632·PLoS One·2008
8-other
A subset of host B lymphocytes controls melanoma metastasis through a melanoma cell adhesion molecule/MUC18-dependent interaction: evidence from mice and humans.
PMID 18922915·Cancer Res·2008
7-preclinical
Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse.
PMID 18718906·J Biol Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 UNIVERSITY OF NEW MEXICO MSC 07 4025, 1201 CAMINO DE SALUD
ALBUQUERQUE, NM 87131 - Phone
- (505) 272-4946
Quick Facts
- NPI
- 1487743092
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile